Notice Number: NOT-RM-12-027
Release Date: June 22, 2012
Office of Strategic Coordination (Common Fund)
This request for information (RFI) seeks to identify organizations with the appropriate expertise and capabilities to sustain, continue to populate and expand the NIH Molecular Imaging and Contrast Agent Database (MICAD: http://micad.nih.gov). This RFI serves to notify the community and to provide all interested parties an opportunity to respond.
MICAD is a freely-accessible online source of scientific information on in vivo molecular imaging and contrast agents. MICAD was initiated in 2004 as a component of the NIH Common Fund Molecular Libraries and Imaging Program. The purpose of MICAD was to create a centralized resource for the scientific community on all peer-reviewed molecular imaging agents. Through resources provided by the NIH Common Fund and the National Library of Medicine (NLM), MICAD now exists as an integrated component of the NLM Bookshelf (http://www.ncbi.nlm.nih.gov/books) and contains information on over 1200 imaging agents. Each MICAD entry is a structured summary of a single molecular imaging agent, and is prepared and reviewed by an expert team of Ph.D.-level scientists. In addition, each MICAD chapter is indexed as an individual entry in PubMed, so the information is accessible to the community through multiple routes. As an example of recent usage of MICAD, there was an average of approximately 13,700 web hits/month during the 6 months between May 2011 and October 2011.
The NIH is now interested in transferring MICAD to a private entity to sustain, continue to populate and expand it for the indefinite future. An ideal partner entity in this venture would be able to provide scientific expertise on molecular imaging agents, computational infrastructure to maintain the database, a plan for maintaining the freely-accessible high quality content of MICAD, and a vision for expanding its utility for the community.
Entities responding to this RFI are requested to submit the following information:
1) Description of the organization's vision for the future of MICAD.
2) Description of the organization's ability to provide freely accessible, high-quality scientific content on molecular imaging agents, and how that content would be clearly and explicitly separated from any opinions, comments or commercially-sponsored content.
3) Description of the resources that the organization would provide to support MICAD.
Responses will be accepted through July 13, 2012. Please email your response to the above inquiries to: email@example.com
In your response, please also provide the following (and include the Notice number NOT-RM-12-027 in the subject line):
Name of the organization/site
Full contact information for the point of contact
Please direct all inquiries to:
Anne E. Menkens, Ph.D.
National Cancer Institute
6130 Executive Blvd., Room 6068
Bethesda, MD 20892
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.